This is a preview of subscription content, log in via an institution to check access.
References
Jansen, B. et al. Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 356, 1728–1733 (2000).
Clayman, G. L. et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin. Oncol. 16, 2221–2232 (1998).
Swisher, S. G. et al. Induction of pro-apoptotic mediators and tumor regression following intratumoral delivery of adenoviral p53 (RPR/INGN201) and radiation therapy in patients with non-small-cell lung cancer. Proc. Am. Soc. Clin. Oncol. 20, A1024 (2001).
Buller, R. E. et al. Multi-dose intraperitoneal (IP) RAD/p53 (SCH58500) gene replacement combined with chemotherapy in heavily pretreated recurrent ovarian cancer is associated with prolonged survival. Proc. Am. Soc. Clin. Oncol. 20, A1047 (2001).
Khuri, F. R. et al. A controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nature Med. 6, 879–885 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhang, J. Apoptosis-based anticancer drugs. Nat Rev Drug Discov 1, 101–102 (2002). https://doi.org/10.1038/nrd742
Issue Date:
DOI: https://doi.org/10.1038/nrd742
- Springer Nature Limited
This article is cited by
-
The promising future of microalgae: current status, challenges, and optimization of a sustainable and renewable industry for biofuels, feed, and other products
Microbial Cell Factories (2018)
-
Synthesis and biological evaluation of novel 4,5-dihydropyrazole derivatives as potent anticancer and antimicrobial agents
Medicinal Chemistry Research (2013)